… We limited our model time horizon to 15 years because (1) 90% of the model population died
within that time frame, (2) the major health economic outcomes were already captured, and …

… The aim of this study was to develop an economic model to assess the cost-effectiveness of
… the safety and efficacy of cardiac resynchronisation therapy in patients with asymptomatic left …

… cardiac valves, electrophysiology catheters, etc.) highlights the need to move from a purely
financial perspective based merely on costs, to an economic … assumptions of the model, and …

… a longer life model would add unnecessary uncertainty and the major health and economic
outcomes could be captured. In addition, the model converged from that time onwards. …

… requiring cardiac resynchronisation therapy with and without a preassessment clinic This
decision tree model was used to estimate the cost of the cardiac resynchronisation therapy …

… on two previous technology assessments that evaluated implantable cardioverter defibrillators
(ICDs) for arrhythmias and cardiac resynchronisation therapy (CRT) for heart failure (HF). …

… With this knowledge, we performed an economic evaluation (EE) for Argentina, using … of
the Model We based our model design on previous cost-effectiveness research (15). Our model …

… patients that could derive clinical benefit should be based on proper economical evaluations.
… cohort enter the model with 60 years of age. Relevant input parameters for the model are …

… A preliminary economic analysis from Germany has concluded that CRT is a cost-effective
intervention. The modestly higher upfront cost (+22% compared with medical treatment) due …

… Economic impact of cardiac resynchronization therapy in patients with heart failure.
Available evidence and evaluation of the CRT-Eucomed model for analysis of cost-effectiveness …